Record imaging performance and accelerating Digital Health ARR drove higher guidance, despite labor costs and continued Digital Health investment.
| Quarter | Q2 FY26 |
|---|---|
| Call date | 2026-08-10 |
| Length | 84 minutes |
| EPS | $0.29 |
| EPS consensus | $0.18 |
| Revenue | $622.7M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q1 FY26 · Q4 FY25 · Q2 FY25
All RDNT earnings · Back to RDNT overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.